BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 25815218)

  • 1. Combined treatment with antiviral therapy and rituximab in patients with mixed cryoglobulinemia: review of the literature and report of a case using direct antiviral agents-based antihepatitis C virus therapy.
    Urraro T; Gragnani L; Piluso A; Fabbrizzi A; Monti M; Fognani E; Boldrini B; Ranieri J; Zignego AL
    Case Reports Immunol; 2015; 2015():816424. PubMed ID: 25815218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virological and Clinical Response to Interferon-Free Regimens in Patients with HCV-Related Mixed Cryoglobulinemia: Preliminary Results of a Prospective Pilot Study.
    Gragnani L; Piluso A; Urraro T; Fabbrizzi A; Fognani E; Petraccia L; Genovesi A; Giubilei L; Ranieri J; Stasi C; Monti M; Zignego AL
    Curr Drug Targets; 2017; 18(7):772-785. PubMed ID: 26853322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in HCV and Cryoglobulinemic Vasculitis in the Era of DAAs: Are We at the End of the Road?
    Bunchorntavakul C; Mitrani R; Reddy KR
    J Clin Exp Hepatol; 2018 Mar; 8(1):81-94. PubMed ID: 29743799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of free light chains in HCV-positive patients with mixed cryoglobulinaemia vasculitis undergoing rituximab treatment.
    Basile U; Gragnani L; Piluso A; Gulli F; Urraro T; Dell'Abate MT; Torti E; Stasi C; Monti M; Rapaccini GL; Zignego AL
    Liver Int; 2015 Sep; 35(9):2100-7. PubMed ID: 25800731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of biomarkers of liver fibrosis and liver insufficiency in hepatitis C virus-infected patients treated with pegylated interferon plus ribavirin and rituximab.
    Geri G; Terrier B; Imbert-Bismut F; Saadoun D; Sène D; Poynard T; Cacoub P
    J Viral Hepat; 2012 Jul; 19(7):497-500. PubMed ID: 22676362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral therapy for hepatitis C virus--associated mixed cryoglobulinemia vasculitis: a long-term followup study.
    Saadoun D; Resche-Rigon M; Thibault V; Piette JC; Cacoub P
    Arthritis Rheum; 2006 Nov; 54(11):3696-706. PubMed ID: 17075881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rituximab combined with Peg-interferon-ribavirin in refractory hepatitis C virus-associated cryoglobulinaemia vasculitis.
    Saadoun D; Resche-Rigon M; Sene D; Perard L; Karras A; Cacoub P
    Ann Rheum Dis; 2008 Oct; 67(10):1431-6. PubMed ID: 18178690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The challenge of treating hepatitis C virus-associated cryoglobulinemic vasculitis in the era of anti-CD20 monoclonal antibodies and direct antiviral agents.
    Roccatello D; Sciascia S; Rossi D; Solfietti L; Fenoglio R; Menegatti E; Baldovino S
    Oncotarget; 2017 Jun; 8(25):41764-41777. PubMed ID: 28454112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefit of direct-acting antiviral therapy for hepatitis C virus (HCV) in monoinfected and HIV-HCV-coinfected patients with mixed cryoglobulinaemia.
    Miailhes P; Hartig-Lavie K; Virlogeux V; Pradat P; Diakite M; Uhres AC; Zoulim F; Sarda MN
    Clin Microbiol Infect; 2018 Nov; 24(11):1215.e1-1215.e4. PubMed ID: 29870852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and Safety of Direct Acting Antivirals for the Treatment of Mixed Cryoglobulinemia.
    Emery JS; Kuczynski M; La D; Almarzooqi S; Kowgier M; Shah H; Wong D; Janssen HLA; Feld JJ
    Am J Gastroenterol; 2017 Aug; 112(8):1298-1308. PubMed ID: 28291241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PEGylated interferon alfa-2b and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis.
    Cacoub P; Saadoun D; Limal N; Sene D; Lidove O; Piette JC
    Arthritis Rheum; 2005 Mar; 52(3):911-5. PubMed ID: 15751068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral therapy of symptomatic HCV-mixed cryoglobulinemia after liver transplant: case report and literature review.
    Francesca Donato M; Banfi G; Cresseri D; Battista Fogazzi G; Martin P; Messa P; Fabrizi F
    Int J Artif Organs; 2013 May; 36(5):367-72. PubMed ID: 23446762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of hepatitis C virus infection in patients with mixed cryoglobulinemic syndrome and cryoglobulinemic glomerulonephritis.
    Rutledge SM; Chung RT; Sise ME
    Hemodial Int; 2018 Apr; 22 Suppl 1():S81-S96. PubMed ID: 29694729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibodies to cytoplasmic rods and rings in patients with hepatitis C virus infection treated with direct-acting antivirals: The role of prior treatment with interferon plus ribavirin.
    Alsius M; Ferri MJ; Buxó M; López C; Serra I; Queralt X; Acero D
    Gastroenterol Hepatol; 2019 Feb; 42(2):82-89. PubMed ID: 30446175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective study of guideline-tailored therapy with direct-acting antivirals for hepatitis C virus-associated mixed cryoglobulinemia.
    Gragnani L; Visentini M; Fognani E; Urraro T; De Santis A; Petraccia L; Perez M; Ceccotti G; Colantuono S; Mitrevski M; Stasi C; Del Padre M; Monti M; Gianni E; Pulsoni A; Fiorilli M; Casato M; Zignego AL
    Hepatology; 2016 Nov; 64(5):1473-1482. PubMed ID: 27483451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy of chronic hepatitis C virus infection in the era of direct-acting and host-targeting antiviral agents.
    Conteduca V; Sansonno D; Russi S; Pavone F; Dammacco F
    J Infect; 2014 Jan; 68(1):1-20. PubMed ID: 24012819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term remission with rituximab in a patient with severe hepatitis C virus-induced mixed cryoglobulinemia.
    Fortea-Ormaechea JI; Lozano-Maya M; Adán-Merino L; Barrio-Antoranz J; Martín-Chavarri S; Corchete-Prats E; Martínez-Acebes E; Aldeguer-Martínez M
    Rev Esp Enferm Dig; 2013 Sep; 105(8):490-3. PubMed ID: 24274448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telaprevir in a patient with chronic hepatitis C and cryoglobulinemic glomerulonephritis.
    De Nicola S; Aghemo A; Campise MR; D'Ambrosio R; Rumi MG; Messa P; Colombo M
    Antivir Ther; 2014; 19(5):527-31. PubMed ID: 24009104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From the pathogenesis to the cure of indolent B-cell lymphoproliferative disorders associated with hepatitis C virus infection: which role for direct-acting antivirals?
    Visentini M; Fiorilli M; Casato M
    Expert Rev Hematol; 2017 Aug; 10(8):719-727. PubMed ID: 28675071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B-cell depletion in the treatment of mixed cryoglobulinemia.
    Sansonno D; Tucci FA; Montrone M; Troiani L; Sansonno L; Gatti P; Lauletta G
    Dig Liver Dis; 2007 Sep; 39 Suppl 1():S116-21. PubMed ID: 17936212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.